Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-02-14 Codner Iris Beck EVP Global Brand&Communication Option exercise · Restricted Share Units −3,212 6,425
2019-02-13 de Notaristefani Carlo Executive VP Global Operations Sale −5,041 $17.88 $90K 12,120.73
2019-02-12 de Notaristefani Carlo Executive VP Global Operations Grant or award +14,432 17,161.73
2019-02-12 de Notaristefani Carlo Executive VP Global Operations Grant or award · Restricted Share Units +1,204 1,204
2019-02-12 Codner Iris Beck EVP Global Brand&Communication Grant or award +6,494 14,784.04
2019-02-12 Sabag Mark EVP, Global Human Resources Grant or award +9,381 50,897.54
2019-01-02 Fridriksdottir Hafrun Executive VP, Global R&D Sale −1,643 $15.70 $26K 11,825.51
2018-12-31 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +4,640 13,468.51
2018-12-31 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −4,640 4,640
2018-11-30 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +2,711 9,761.51
2018-11-30 Fridriksdottir Hafrun Executive VP, Global R&D Sale −933 $21.76 $20K 8,828.51
2018-11-30 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −2,711 8,133
2018-11-05 McClellan Michael James EVP, Chief Financial Officer Option exercise +695 11,990.27
2018-11-05 McClellan Michael James EVP, Chief Financial Officer Sale −346 $22.73 $8K 11,644.27
2018-11-05 McClellan Michael James EVP, Chief Financial Officer Option exercise · Restricted Share Units −695 695
2018-09-18 O'Grady Brendan P. EVP, North America Commercial Option exercise +1,241 2,629.49
2018-09-18 O'Grady Brendan P. EVP, North America Commercial Sale −1,241 $23.71 $29K 1,388.49
2018-09-18 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −1,241 1,241
2018-09-18 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise +2,638 8,384.36
2018-09-18 Nazzi Gianfranco EVP, Growth Markets Commercial Sale −1,379 $23.69 $33K 7,005.36

Page 69 of 76 · 1,517 trades